Author:
Zhu Yao,Freedland Stephen J.,Ye Dingwei
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference12 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68:394–424.
2. Li N, Huang HY, Wu DW, Yang ZM, Wang J, Wang JS, et al. Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review. Lancet Oncol. 2019;20:e619–26.
3. Zhang Y, Xu L, Chang Y, Li Y, Butler W, Jin E, et al. Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC. Prostate Cancer Prostatic Dis. 2019, https://doi.org/10.1038/s41391-019-0172-z.
4. Zhai L, Fan Y, Meng Y, Feng X, Yu W, Jin J. The role of prostate imaging reporting and data system score in gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis. Prostate Cancer Prostatic Dis. 2019;22:235–43.
5. Matsumoto K, Akita H, Narita K, Hashiguchi A, Takamatsu K, Takeda T, et al. Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer. Prostate Cancer Prostatic Dis. 2019;22:539–45.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献